AKAN
Akanda Corp.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · GB
$3.22
+9.52%Margins
Gross margin
-382.7%
EBITDA margin
-1881.5%
EBIT margin
-2022.7%
Net margin
—
FCF margin
-3085.6%
422.5%
Return on equity
-735.6%
Return on assets
-151.2%
Return on invested capital
0.04x
Asset turnover
-$6.7M
Cash from operations
$0.93
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Dec 1, 2025